anti-inflammatory drugs (NSAIDs) are commonly used agents for backache and various joint pains. We suspected that a continuous administration of NSAIDs might suppress bone formation and/or promote bone loss in patients with low bone mineral density (BMD) because the biosynthesis of prostagrandins is inhibited by these drugs. In this study we surveyed the effect of NSAIDs on the bone metabolism in patients with low BMD by comparing a group with NSAIDs administered every day over a period of 1 year and a control group with NSAIDs only occasionally used.
Drugs (NSAIDs) on Osteoporosis
Shoji KUMAKI* and Hideki KURIBAYASHr Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used agents for backache and various joint pains. We suspected that a continuous administration of NSAIDs might suppress bone formation and/or promote bone loss in patients with low bone mineral density (BMD) because the biosynthesis of prostagrandins is inhibited by these drugs. In this study we surveyed the effect of NSAIDs on the bone metabolism in patients with low BMD by comparing a group with NSAIDs administered every day over a period of 1 year and a control group with NSAIDs only occasionally used.
Dual energy x-ray absorptiometry (DXA) was performed on a total of 272 female at our department from April 1999 to September 1999. As a result, 163 cases were found to have BMD less than 80% of the nation's young adult mean values and considered non-secondary in nature. Out of the 163, we chose 14 cases for the NSAID group, and 51 cases for the control group.
The average age, height and body weight were 73.6 years, 149.1cm and 52.1kg for the NSAID group and 71.7 years, 146.7cm and 48.0kg for the control group. There were no statistical differences in all these items. For the treatment of low BMD, 64.9% of the patients in the NSAID group and 52.9% in the control group had anti-osteoporotic medication. In the NSAID group, the relative changes in BMD between the values of the first measurements and those after a 1-year interval were 2.7% decrease at 2nd lumbar vertebra (L2), 12.4% decrease at 3rd lumbar vertebra (L3), 3.9% decrease at 4th lumbar vertebra (L4) and 4.4% decrease at 2nd-4th lumbar vertebra (L2-4). In the control group these were at each site 2.9% increase, 3.6% increase, 2.3% increase and 2.8% increase, respectively. In the NSAID group, BMD changes at neck, Wards, trochanter and shaft of the femur were 3.6% decrease, 4.6% decrease, 4.2% decrease and 3.9% decrease, respectively in the control group, they were 1.0% decrease, 2.2% increase, 1.6% increase and 0.1% increase, respectively. A comparison between the two groups showed thaf the percent changes in BMD of L3, L2-4, Wards, trochanter and shaft of the femur were statistically significant in the NSAID groups.
The present data suggest that the regular use of NSAIDs enhances bone loss in patients with low bone density detected by DXA examination. press bone formation and promote bone loss in patients with low bone density because NSAIDs inhibit prostaglandin production in the body, leading to a decreased rate of bone formation.
Introduction
In this study, we tried to detect the effect of NSAIDs on the bone metabolism in patients with low bone density.
We have compared two groups over a period of 1 year: one, a group of patients with low bone density to whom NSAIDs were administered regularly and the other , a control group of patients with low bone density to whom NSAIDs were dispenced only occasionally.
Subjects and Method
In our department from April 1, 1999 to Out of the 163, we selected for the NSAID group, 14 cases to whom NSAIDs (diclofenac sodium, 5 sases ; loxoprofen sodium, 3 cases; nabumetone, 2 cases ; etodolac, 2 cases; zoltoprofen, 2 cases ; ampiroxicam, 1 cases; and alminoprofen, 1 case) had been administered every day and had been followed up over 1 year.
For the control group, we chose 51 cases to whom NSAIDs were not given at all or only occationally over the same period.
For the measurement of BMD, the DXA apparatus (Expert 2000, lunar company, USA) was used. The bone density of each lumbar vertebra from the second to fourth was measured separately and synthesized for combined area if necessary. In the proximal femur , bone density was measured by deviding the interest area into four parts, which are designated the "neck", "Wards", "trochanter" and "shaft" in the E xpert 2000 BMD report. The value of BMD in Wards is the computer caluculated minimal density figure about the certain square area in the neck, which is not geographically equivalent to Ward's triangle of the femoral neck (Fig. 1) .
In addition to BMD data, we compared two Table 1) .
Assessment of ADL: In the NSAID group
there were three grade 3s, and 11 grade 5s. In the control group there were one grade 1, three grade 2s, six grade 3s and 34 grade 5s. The Mann Whitney U-test analysis showed no significant difference (P = 0.174). 
